{"transactions":[{"id":705002,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-22T20:30:25.000Z","date":"2026-07-21","kind":"sale","planned":false,"acquired":false,"shares":1478,"price":6.53,"value":9651.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards."}],"balance_after":492079,"source":{"system":"sec-edgar","filing":"0001493152-26-034246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226034246/ownership.xml","form_type":"4"}},{"id":712241,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-09T23:24:48.000Z","date":"2026-07-09","kind":"sale","planned":false,"acquired":false,"shares":24880,"price":6.9637,"value":173256.856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":493557,"source":{"system":"sec-edgar","filing":"0001493152-26-032746","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226032746/ownership.xml","form_type":"4"}},{"id":745558,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:55.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":25646,"price":5.3922,"value":138288.3612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":518437,"source":{"system":"sec-edgar","filing":"0001493152-26-028022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028022/ownership.xml","form_type":"4"}},{"id":745557,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:55.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":13421,"price":5.3042,"value":71187.6682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":544083,"source":{"system":"sec-edgar","filing":"0001493152-26-028022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028022/ownership.xml","form_type":"4"}},{"id":745556,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:55.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":10271,"price":5.4295,"value":55766.3945,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":557504,"source":{"system":"sec-edgar","filing":"0001493152-26-028022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028022/ownership.xml","form_type":"4"}},{"id":842991,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T20:29:01.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":785,"price":4.76,"value":3736.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."}],"balance_after":567775,"source":{"system":"sec-edgar","filing":"0001493152-26-010276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226010276/ownership.xml","form_type":"4"}},{"id":933855,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T01:34:02.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":18666,"price":5.3309,"value":99506.5794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":568560,"source":{"system":"sec-edgar","filing":"0001493152-26-003284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003284/ownership.xml","form_type":"4"}},{"id":936520,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:31:52.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":133595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029."}],"balance_after":587226,"source":{"system":"sec-edgar","filing":"0001493152-26-002889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226002889/ownership.xml","form_type":"4"}},{"id":1030107,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-01T20:30:09.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":9035,"price":5.3935,"value":48730.2725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.46 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":453631,"source":{"system":"sec-edgar","filing":"0001493152-25-016542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225016542/ownership.xml","form_type":"4"}},{"id":1065937,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T20:30:22.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":7.3572,"value":110358.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.48 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":462666,"source":{"system":"sec-edgar","filing":"0001493152-25-012099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225012099/ownership.xml","form_type":"4"}},{"id":1083671,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-22T20:15:23.000Z","date":"2025-07-22","kind":"sale","planned":false,"acquired":false,"shares":1502,"price":6.6409,"value":9974.6318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.63 to $6.65 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":477666,"source":{"system":"sec-edgar","filing":"0001641172-25-020575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225020575/ownership.xml","form_type":"4"}},{"id":1089820,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-10T20:30:37.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":25411,"price":5.8557,"value":148799.1927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":479168,"source":{"system":"sec-edgar","filing":"0001641172-25-018604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225018604/ownership.xml","form_type":"4"}},{"id":1118942,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-09T20:31:37.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of June 5, 2026, June 5, 2027, and June 5, 2028."}],"balance_after":504579,"source":{"system":"sec-edgar","filing":"0001641172-25-014321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225014321/ownership.xml","form_type":"4"}},{"id":1120522,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-06T22:04:04.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":17795,"price":6.76,"value":120294.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.76 to $6.79 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":491246,"source":{"system":"sec-edgar","filing":"0001641172-25-014178","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225014178/ownership.xml","form_type":"4"}},{"id":1205054,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2025-03-17T20:30:19.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":685,"price":5.29,"value":3623.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":509041,"source":{"system":"sec-edgar","filing":"0001493152-25-010591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225010591/ownership.xml","form_type":"4"}},{"id":1295683,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-01-25T01:10:53.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the anniversary of the grant and are exercisable beginning as of that date."}],"balance_after":25000,"derivative":{"exercise_price":1.01,"exercise_date":"2025-01-22","expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-001854","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925001854/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-01-24"}},{"id":1295677,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-01-24T21:13:53.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":25000,"derivative":{"exercise_price":1.01,"exercise_date":"2025-01-22","expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-001796","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925001796/rdgdoc.xml","form_type":"4"}},{"id":1297027,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2025-01-23T23:56:56.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":144509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 21, 2026, January 21, 2027 and January 21, 2028."}],"balance_after":509726,"source":{"system":"sec-edgar","filing":"0001493152-25-003464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225003464/ownership.xml","form_type":"4"}},{"id":1398214,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-09-30T20:30:32.000Z","date":"2024-09-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":6388,"price":5.89,"value":37625.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":365217,"source":{"system":"sec-edgar","filing":"0001493152-24-038799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224038799/ownership.xml","form_type":"4"}},{"id":1450787,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-07-22T20:30:32.000Z","date":"2024-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1055,"price":5.11,"value":5391.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":371605,"source":{"system":"sec-edgar","filing":"0001493152-24-028697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224028697/ownership.xml","form_type":"4"}},{"id":1458010,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-07-09T20:35:39.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":155200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of July 8, 2025, July 8, 2026 and July 8, 2027."}],"balance_after":372660,"source":{"system":"sec-edgar","filing":"0001493152-24-026648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026648/ownership.xml","form_type":"4"}},{"id":1487729,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-06-07T20:33:18.000Z","date":"2024-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":16408,"price":4.52,"value":74164.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":217460,"source":{"system":"sec-edgar","filing":"0001493152-24-023125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224023125/ownership.xml","form_type":"4"}},{"id":1535063,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-04-26T12:30:35.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":5608,"price":3.14,"value":17609.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.13 to $3.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":233868,"source":{"system":"sec-edgar","filing":"0001493152-24-016062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224016062/ownership.xml","form_type":"4"}},{"id":1575787,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2024-03-15T21:00:25.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":703,"price":8.14,"value":5722.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":228260,"source":{"system":"sec-edgar","filing":"0001493152-24-010132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224010132/ownership.xml","form_type":"4"}},{"id":1771884,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-09-29T21:17:54.000Z","date":"2023-09-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":6230,"price":3.93,"value":24483.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":228963,"source":{"system":"sec-edgar","filing":"0001493152-23-034904","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034904/ownership.xml","form_type":"4"}},{"id":1776575,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-09-20T13:00:10.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":2986,"price":3.82,"value":11406.52,"ownership":{"direct":true},"balance_after":238179,"source":{"system":"sec-edgar","filing":"0001493152-23-033142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223033142/ownership.xml","form_type":"4"}},{"id":1776574,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-09-20T13:00:10.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":14,"price":3.7,"value":51.8,"ownership":{"direct":true},"balance_after":235193,"source":{"system":"sec-edgar","filing":"0001493152-23-033142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223033142/ownership.xml","form_type":"4"}},{"id":1823821,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-07-26T00:10:28.000Z","date":"2023-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1187,"price":3.73,"value":4427.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld\nshares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":235179,"source":{"system":"sec-edgar","filing":"0001493152-23-025515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223025515/ownership.xml","form_type":"4"}},{"id":1864607,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-06-07T20:15:39.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":141908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026."}],"balance_after":236366,"source":{"system":"sec-edgar","filing":"0001493152-23-020416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223020416/ownership.xml","form_type":"4"}},{"id":1948925,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2023-03-17T20:05:34.000Z","date":"2023-03-15","kind":"tax_withholding","acquired":false,"shares":792,"price":2.6,"value":2059.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e)."}],"balance_after":94458,"source":{"system":"sec-edgar","filing":"0001493152-23-008076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223008076/ownership.xml","form_type":"4"}},{"id":2109544,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2022-11-21T14:00:12.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":2500,"price":4,"value":10000.0,"ownership":{"direct":true},"balance_after":95250,"source":{"system":"sec-edgar","filing":"0001493152-22-033018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222033018/ownership.xml","form_type":"4"}},{"id":2149084,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2022-09-30T20:05:29.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":72750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026."}],"balance_after":92750,"source":{"system":"sec-edgar","filing":"0001493152-22-027277","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027277/ownership.xml","form_type":"4"}},{"id":2202984,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2022-07-25T22:17:28.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of July 21, 2023, July 21, 2024, July 21, 2025 and July 21, 2026."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-22-020281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222020281/ownership.xml","form_type":"4"}},{"id":2332017,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2022-03-16T20:08:13.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of March 14, 2023, March 14, 2024, March 14, 2025 and March 14, 2026."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001493152-22-006976","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222006976/ownership.xml","form_type":"4"}},{"id":2463510,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-20T22:07:19.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":100505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit award (RSU) vests on March 15, 2022. Each RSU is equivalent to one share of the Company's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100,505 RSUs."}],"balance_after":165757,"source":{"system":"sec-edgar","filing":"0001104659-21-151771","document":"tm2135922-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465921151771/tm2135922-3_4seq1.xml","form_type":"4"}},{"id":2568650,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-15T20:03:13.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":7160,"price":1.62,"value":11599.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2021, a total of 7,160 shares were sold by the Company at a weighted average sales price of $1.62 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."}],"balance_after":65252,"source":{"system":"sec-edgar","filing":"0001104659-21-115916","document":"tm2127741-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465921115916/tm2127741-1_4seq1.xml","form_type":"4"}},{"id":3049516,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-21T20:15:46.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":3840,"price":12.13,"value":46579.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 20, 2020, a total of 3,840 shares were sold by the Company at a weighted average sales price of $12.13 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."}],"balance_after":57412,"source":{"system":"sec-edgar","filing":"0001104659-20-097594","document":"tm2029210d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465920097594/tm2029210d1_4.xml","form_type":"4"}},{"id":3217045,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-10T20:42:26.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":1889,"price":7.94,"value":14998.66,"ownership":{"direct":true},"balance_after":61252,"source":{"system":"sec-edgar","filing":"0001104659-20-031410","document":"tm2012321d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/tm2012321d1_form4.xml","form_type":"4"}},{"id":3217044,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-10T20:42:26.000Z","date":"2020-03-09","kind":"purchase","acquired":true,"shares":100,"price":7.97,"value":797.0,"ownership":{"direct":true},"balance_after":59363,"source":{"system":"sec-edgar","filing":"0001104659-20-031410","document":"tm2012321d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/tm2012321d1_form4.xml","form_type":"4"}},{"id":3217043,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-10T20:42:26.000Z","date":"2020-03-09","kind":"purchase","acquired":true,"shares":1400,"price":7.99,"value":11186.0,"ownership":{"direct":true},"balance_after":59263,"source":{"system":"sec-edgar","filing":"0001104659-20-031410","document":"tm2012321d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/tm2012321d1_form4.xml","form_type":"4"}},{"id":3248163,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-25T21:55:57.000Z","date":"2020-02-25","kind":"purchase","acquired":true,"shares":1200,"price":9.09,"value":10908.0,"ownership":{"direct":true},"balance_after":57863,"source":{"system":"sec-edgar","filing":"0001104659-20-024815","document":"tm2010943d12_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465920024815/tm2010943d12_4.xml","form_type":"4"}},{"id":3273312,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-13T21:32:03.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."}],"balance_after":50505,"derivative":{"exercise_price":0,"expiration_date":"2025-02-12","underlying":"Common Stock","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001104659-20-020237","document":"tm208004-2_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465920020237/tm208004-2_form4.xml","form_type":"4"}},{"id":3440740,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-12T20:19:44.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":2375,"price":5.56,"value":13205.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 9, 2019, a total of 2,375 shares were sold by the Company at a weighted average sales price of $5.56 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."}],"balance_after":56663,"source":{"system":"sec-edgar","filing":"0001144204-19-039191","document":"tv527358_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000114420419039191/tv527358_4.xml","form_type":"4"}},{"id":3440739,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-12T20:19:44.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":2313,"price":5.62,"value":12999.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2019, a total of 2,313 shares were sold by the Company at a weighted average sales price of $5.62 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."}],"balance_after":59038,"source":{"system":"sec-edgar","filing":"0001144204-19-039191","document":"tv527358_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000114420419039191/tv527358_4.xml","form_type":"4"}},{"id":3499918,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-06-05T20:42:15.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":27778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."}],"balance_after":27778,"derivative":{"exercise_price":0,"expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":27778},"source":{"system":"sec-edgar","filing":"0001144204-19-029900","document":"tv523099_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000114420419029900/tv523099_form4.xml","form_type":"4"}},{"id":3849330,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Corp. Controller"}}],"security":"Common Stock","published_at":"2018-08-09T01:50:11.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted common stock will vest as follows: one-fourth on August 7, 2019, one-fourth on August 7, 2020, one-fourth on August 7, 2021, and one-fourth on August 7, 2022."}],"balance_after":61351,"source":{"system":"sec-edgar","filing":"0001144204-18-042965","document":"tv500471_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000114420418042965/tv500471_form4.xml","form_type":"4"}},{"id":3881139,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":29232,"kind":"person","name":"Vazzano Joseph Walter","position":1,"cik":"0001715291","reported_name":"Vazzano Joseph Walter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & Corp. Controller"}}],"security":"Common Stock","published_at":"2018-06-28T17:09:10.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":1351,"price":3.66,"value":4944.66,"ownership":{"direct":true},"balance_after":31351,"source":{"system":"sec-edgar","filing":"0001144204-18-036289","document":"tv497535_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000114420418036289/tv497535_form4.xml","form_type":"4"}}]}